Visitor Monitoring Drug History: LEUSTATIN
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: LEUSTATIN
FDA Application No: (NDA) 020229
Active Ingredient(s): CLADRIBINE
Company: ORTHO BIOTECH
 
Label History
 
View the label approved on April 7, 2003 for LEUSTATIN, (NDA) 020229


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
6/29/2006 030Labeling Revision Letter 
4/23/2002 028Control Supplement  
11/7/2001 027Control Supplement  
11/7/2001 026Manufacturing Change or Addition  
1/19/2001 025Control Supplement  
10/24/2000 024Control Supplement  
4/11/2000 023Manufacturing Change or Addition  
2/9/2000 022Manufacturing Change or Addition  
8/22/2002 021Labeling Revision Letter 
7/14/1998 020Manufacturing Change or Addition  
7/14/1998 019Expiration Date Change  
2/18/1998 018Control Supplement  
2/26/1998 017Control Supplement  
2/9/1998 016Manufacturing Change or Addition  
12/29/1997 015Control Supplement  
12/3/1997 014Manufacturing Change or Addition  
9/18/1997 013Control Supplement  
7/28/1997 012Manufacturing Change or Addition  
7/24/1997 011Control Supplement  
7/24/1997 010Control Supplement  
7/24/1997 009Expiration Date Change  
4/18/1997 008Control Supplement  
8/20/2002 007Labeling Revision Letter 
10/23/1996 006Control Supplement  
4/18/1996 005Control Supplement  
8/20/2002 004Labeling Revision Letter 
3/16/1994 003Manufacturing Change or Addition  
9/1/1994 002Manufacturing Change or Addition  
7/28/1993 001Control Supplement  
2/26/1993 000Approval Label 
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test